Antimicrobial Agents and Chemotherapy

Title Publication Date Language Citations
Comparison of Immunogenicity and Safety of a Virosome Influenza Vaccine with Those of a Subunit Influenza Vaccine in Pediatric Patients with Cystic Fibrosis2000/05/01English
Detection of Resistance to Amphotericin B in Candida Isolates by Using Iso-Sensitest Broth2001/07/01English
In Vitro and In Vivo Activities of Aminoadamantane and Aminoalkylcyclohexane Derivatives against Trypanosoma brucei2001/05/01English
Antibacterial Activities and Pharmacokinetics of E-4767 and E-5065, Two New 8-Chlorofluoroquinolones with a 7-Azetidin Ring Substituent2001/11/01English
Association of Metronidazole Resistance and Natural Competence in Helicobacter pylori2002/05/01English
Gentamicin Increases the Efficacy of Vancomycin against Penicillin-Resistant Pneumococci in the Rabbit Meningitis Model2002/01/01English
The Ovine Cathelicidin SMAP29 Kills Ovine Respiratory Pathogens In Vitro and in an Ovine Model of Pulmonary Infection2001/01/01English
In Vitro Antifungal Susceptibilities of Trichosporon Species2002/04/01English
Expression of lux Genes in a Clinical Isolate of Streptococcus pneumoniae : Using Bioluminescence To Monitor Gemifloxacin Activity2002/02/01English
Potent Antipneumococcal Activity of Gemifloxacin Is Associated with Dual Targeting of Gyrase and Topoisomerase IV, an In Vivo Target Preference for Gyrase, and Enhanced Stabilization of Cleavable Complexes In Vitro2000/11/01English
In Vitro Activities of Approved and Investigational Antifungal Agents against 44 Clinical Isolates of Basidiomycetous Fungi2001/02/01English
A Tight-Binding Mode of Inhibition Is Essential for Anti-Human Immunodeficiency Virus Type 1 Virucidal Activity of Nonnucleoside Reverse Transcriptase Inhibitors2002/06/01English
Novel Use of a Guanosine Prodrug Approach To Convert 2',3'-Didehydro-2',3'-Dideoxyguanosine into a Viable Antiviral Agent2002/03/01English
In Vitro Growth of Leishmania amazonensis Promastigotes Resistant to Pentamidine Is Dependent on Interactions among Strains2001/06/01English
Staphylococcus aureus Mutants Selected by BMS-2847562001/11/01English
In Vitro Selection of Mutations in the Human Immunodeficiency Virus Type 1 Reverse Transcriptase That Decrease Susceptibility to (−)-β- d -Dioxolane-Guanosine and Suppress Resistance to 3′-Azido-3′-Deoxythymidine2000/07/01English
Safety and Pharmacokinetics of Multiple 750-Milligram Doses of Intravenous Levofloxacin in Healthy Volunteers2001/07/01English
Pharmacokinetics of the Protease Inhibitor Indinavir in Human Immunodeficiency Virus Type 1-Infected Children2001/03/01English
Penicillin-Binding Proteins in Leptospira interrogans2001/03/01English
Integron-Locatedoxa-32Gene Cassette Encoding an Extended-Spectrum Variant of OXA-2 β-Lactamase fromPseudomonas aeruginosa2002/02/01English
Clearance of Infection withMycobacterium bovisBCG in Mice Is Enhanced by Treatment with S28463 (R-848), and Its Efficiency Depends on Expression of Wild-TypeNramp1(Resistance Allele)2001/11/01English
Prevention and Treatment of Lethal Murine Endotoxemia by the Novel Immunomodulatory Agent MFP-142001/05/01English
Coordinate Suppression of Superantigen-Induced Cytokine Production and T-Cell Proliferation by a Small Nonpeptidic Inhibitor of Class II Major Histocompatibility Complex and CD4 Interaction2000/04/01English
Mechanisms of Macrolide Resistance in Clinical Group B Streptococci Isolated in France2001/06/01English
C-Terminal Region of Pseudomonas aeruginosa Outer Membrane Porin OprD Modulates Susceptibility to Meropenem2001/06/01English
Pharmacodynamics of Gemifloxacin against Streptococcus pneumoniae in an In Vitro Pharmacokinetic Model of Infection2001/10/01English
Resistance to Moxifloxacin in Toxigenic Clostridium difficile Isolates Is Associated with Mutations in gyrA2001/08/01English
Single-Dose Intrapulmonary Pharmacokinetics of Rifapentine in Normal Subjects2000/04/01English
Lack of Interaction of Fluoroquinolones with Lipopolysaccharides2002/05/01English
Fluconazole Penetration into the Pancreas2000/09/01English